NEW YORK (360Dx) – Genesis Biotechnology Group announced today that it has acquired the assets of 4path, an Illinois-based anatomic and clinical pathology lab.
According to Genesis, the acquisition is expected to expand the reach of its diagnostics branch — which includes Hamilton, New Jersey-based Medical Diagnostic Laboratories — and allow it to establish a rapid response clinical lab in the Midwest.
Specific terms of the deal were not disclosed.
"This collaboration is an excellent fit with our mission to improve patient care and advance the quality of treatment options through the development and delivery of world class diagnostics," Genesis CEO Eli Mordechai said in a statement. "It brings together highly complementary services that enable clients to have access to a comprehensive portfolio of clinical diagnostic services in multiple therapeutic areas."